Skip to main content

Table 2 Baseline demographic and clinical characteristics in individuals with progressive glycemic impairment compared to no change at 2.5 years

From: Circulating micrornas associated with glycemic impairment and progression in Asian Indians

Characteristics Mean ± SD, Median (IQR), or n (%)

Progressive Glycemic Impairment (n = 23)

No Change (n = 71)

p-value

Sex (male)

14 (61)

41 (58)

0.070

Age (years)

55 ± 9

57 ± 9

0.310

Current Smoking

8 (9)

3 (4)

0.705

Physical Activity (MET-minutes/week)

1260 (473, 2100)

1470 (613, 2940)

0.293

Systolic Blood Pressure (mm Hg)

119 ± 20

122 ± 17

0.420

Diastolic Blood Pressure (mm Hg)

71 ± 13

71 ± 10

0.942

Total Cholesterol (mg/dL)

188 ± 39

188 ± 29

0.955

LDL-c (mg/dL)

113 ± 33

112 ± 27

0.872

HDL-c (md/dL)

51 ± 16

50 ± 14

0.780

Triglycerides (mg/dL)

120 ± 65

126 ± 56

0.676

Fasting Blood Glucose (mg/dL)

91 ± 8

91 ± 11

0.813

Insulin (μIU/mL)

11.5 ± 6.2

11.5 ± 6.2

0.807

HOMA-IR (μIU/mL*mmol/L)

2.6 ± 1.5

2.8 ± 2.1

0.715

Body Mass Index (kg/m2)

25.7 ± 4.7

25.9 ± 4.5

0.878

Waist Circumference (cm)

93 ± 12

94 ± 12

0.856

  1. cm centimeters, HDL-c high density lipoprotein cholesterol, HOMA-IR homeostasis model assessment-insulin resistance, kg/m 2 kg per meter2, LDL-c low density lipoprotein cholesterol, mcU/mL microUnit per milliliter, mg/dL milligrams per deciliter, mm Hg millimeters of mercury, SD standard deviation